TD Cowen has revised its price target for HCA Healthcare (HCA) but maintains a bullish outlook on the company's stock.

Bernstein maintains a bullish stance on HCA Healthcare (HCA), projecting EBITDA growth of 2.8% in 2026 and 4.6% in 2027 for the healthcare provider.

An analysis questions whether HCA Healthcare stock is underperforming in comparison to the broader S&P 500 index.

The article provides an analysis of HCA Healthcare's performance, noting a target cut but still crediting the company's execution.

HCA Healthcare announced a $150 million financial impact in its first quarter earnings, attributed to the lapse of subsidies under the Affordable Care Act.

Multiple exchange-traded funds (ETFs) from Mackenzie, Franklin, and CIBC have announced their latest dividend declarations. These declarations include specific per-unit amounts for various bond, income, and cash management ETFs.

Newmont Corporation reported stronger-than-expected quarterly profits, driven by robust gold prices. Similarly, HCA Healthcare also exceeded its quarterly profit estimates, despite experiencing lower flu season volumes.

A civil rights complaint filed by Do No Harm accuses Corewell Health, Texas Tech, and HCA Healthcare of prioritizing foreign-trained doctors over US-trained graduates in highly sought-after residency programs.

HCA Healthcare's stock is experiencing quiet compounding, which is altering its growth narrative. This steady performance suggests a significant long-term impact.

HCA Healthcare (HCA) has announced an agreement to acquire The College of Health Care Professions, expanding its educational and healthcare training portfolio.

An analysis explores whether Wall Street analysts hold a bullish or bearish outlook on HCA Healthcare stock, providing insights into market sentiment.

HCA Healthcare provided highlights from its first-quarter earnings call, outlining the company's financial results and operational updates. The summary covered key aspects discussed during the call.

At HCA Healthcare's Annual General Meeting, directors were elected and a pay vote passed, while several shareholder proposals failed.

HCA Healthcare projects a 2% to 3% volume growth and maintains its 2026 outlook, despite facing a significant $600 million to $900 million exchange headwind.

HCA Healthcare's stock has slipped as the company's first-quarter 2026 results were negatively impacted by lower patient volumes.

L1 Capital International reduced its stake in HCA Healthcare (HCA), citing valuation considerations as the primary reason for the adjustment.

Jim Cramer advised investors to purchase HCA Healthcare stock in significant quantities, suggesting a strong conviction in the company.

An analysis explores whether HCA Healthcare stock represents a trap for investors or a missed opportunity.

HCA Healthcare announced its financial results for Q1 2026, reporting significant growth with revenues reaching $19.1 billion.

HCA Healthcare (HCA) is reportedly expanding its funding strategy, though specific details of the new approach were not immediately available.

HCA Healthcare has announced a proposed public offering of senior notes, a move typically used to raise capital for various corporate purposes.

This article provides a summary of HCA Healthcare, Inc.'s earnings call for the first quarter of 2026, detailing the company's financial performance and outlook.

HCA Healthcare reported quarterly profits that surpassed analyst estimates, driven by robust demand for medical care services.

Investors are preparing for HCA Healthcare's upcoming earnings release, with key information provided on what to expect from the report.

An analysis suggests that HCA Healthcare could become a long-term winner due to the demographic trend of America's aging population, impacting the healthcare sector.